Work

Efficacy and Safety of Nintedanib in Patients with Systemic Sclerosis-Associated Interstitial Lung Disease: Subgroup Analysis of the SENSCIS Trial by Corticosteroid Use*

Year: 2020

Type: conference-paper

Source: Pneumologie

DOI: 10.1055/s-0039-3403188

Authors: R Wiewrodt, M Vonk, O Distler, D Furst, E Hachulla, S Johnson, S Assassi, L Meng, M Quaresma, M Alves, E Clerisme-Beaty, WA Wuyts

Institutions: University Hospital Münster, Radboud University Medical Center, University Hospital Zurich, University of California, Los Angeles, Université de Lille, Hôpital Claude Huriez, Mount Sinai Hospital, University of Toronto, Toronto Western Hospital, Boehringer Ingelheim (United States), Boehringer Ingelheim (Germany), Universitair Ziekenhuis Leuven

Language: English

Topic: Systemic Sclerosis and Related Diseases

Subfield: Pathology and Forensic Medicine

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W3014314872

FWCI: 3.057

Cites:

Cited by: 1

Related to: 10